Etanercept or adalimumab ( DrugBank: Etanercept, Adalimumab )

1 disease

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	3

46. Malignant rheumatoid arthritis

Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01021735 (ClinicalTrials.gov)	April 2010	27/11/2009	Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy	Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy	Rheumatoid Arthritis	Drug: etanercept or adalimumab;Drug: Rituximab	University of Glasgow	Arthritis Research Campaign;NHS Lothian;NHS Grampian;NHS Tayside;NHS Borders;NHS Fife	Completed	18 Years	N/A	Both	302	Phase 4	United Kingdom
2	NCT01060098 (ClinicalTrials.gov)	April 2010	29/1/2010	T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade	T Cells and TNF: The Impact of TNF Blockade on Effector T Cell Populations in Rheumatoid Arthritis a ...	Rheumatoid Arthritis;Ankylosing Spondylitis;Psoriatic Arthritis	Drug: anti-TNF therapy (etanercept or adalimumab)	Imperial College London	NULL	Completed	18 Years	80 Years	All	48		United Kingdom
3	NCT00808210 (ClinicalTrials.gov)	March 5, 2009	11/12/2008	A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Metho ...	A PHASE II RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF OCR ...	Rheumatoid Arthritis	Drug: Infliximab;Drug: Methotrexate;Drug: Methylprednisolone;Drug: Ocrelizumab;Drug: Placebo	Genentech, Inc.	NULL	Terminated	18 Years	N/A	All	28	Phase 2	United States

First Previous1Next Last